About Nanosphere
Nanosphere is a Healthcare company based in Northbrook (United States) founded in 1999, and was acquired by Luminex in May 2016. Diagnostic tests for personalized medicine targeting infections are provided. It operates in the Healthcare and Technology sectors. Nanosphere has raised $97.75 million across 11 funding rounds from investors including NIH, Luminex Corporation and Takara Bio. The company has 146 employees. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Probes and Dyes. Its legal entity is NANOSPHERE, INC. Its competitors include Denali Therapeutics, Poseida Therapeutics and Castle Biosciences; 3 of its 3 listed competitors have raised funding.
Company details
Nanosphere was founded in 1999 and is based in Northbrook, United States. Diagnostic tests for personalized medicine are developed and supplied, with a focus on infections in the bloodstream, respiratory tract, and gastrointestinal tract. The Verigene System is employed, incorporating automation and proprietary chemistry for direct nucleic acid and protein detection on a single platform. All tests are constructed using gold nanoparticle probe technology within the healthcare diagnostics sector.
- Headquarters Northbrook, United States
- Employees 146
- Stage Acquired
- SectorsHealthcareTechnology
- Website nanosphere.us/support/flex-usage-support
- Social LinkedIn X
- Acquired by Luminex (May 2016)
- Legal Name Nanosphere, Inc.
Funding Insights of Nanosphere
Nanosphere has successfully raised a total of $97.75M across 11 strategic funding rounds. The most recent funding activity was a Post-IPO round of $970.97 thousand completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $97.75M
- Total Rounds 11
- Last Round Post-IPO — $970,967
- First Round $3M
(Mar 2000)
- Investors Count 9
Latest 10 of 11 funding rounds of Nanosphere with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2018 | $970,967 | Post-IPO | – | – | – |
| May 2015 | $30M | Debt – Conventional | – | – | |
| Mar 2010 | $279,000 | Grant | – | – | |
| May 2006 | $57M | Series D | – | Bain Capital Ventures | |
| Oct 2004 | $17M | Series C | – | – | – |
| Jan 2003 | $5M | Series C | – | – | |
| Nov 2002 | $10M | Series C | – | Ann Lurie | |
| Sep 2002 | $1.5M | Grant | – | – | |
| Apr 2002 | $250,000 | Series B | – | – | – |
| Mar 2001 | $5.5M | Series B | – | – | – |
10 investors in total: 10 institutional.
Investors in Nanosphere
Nanosphere has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, Luminex Corporation and Takara Bio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| lsafunding.com | ||||
Venture capital fund focused on investing in multiple sectors | baincapitalventures.com | Boston, United States | ||
Investments and advisory services are provided by the holding company. | 2009 | swkhold.com | Dallas, United States | |
Administers health care and support for military personnel and operations. | health.mil | Falls Church, United States | ||
Wealth management firm | 1932 | alleninvestments.com | Lakeland, United States | |
It serves as a private foundation focused on children welfare. | 1986 | annlurie.com | Chicago, United States | |
Developer of gene-based therapies as well as contract services for the industrial and agricultural sector | 1925 | takara-bio.com | Frankfurt, Germany | |
Facilitates development, knowledge sharing, and networking for emerging VC investors. | nextgenpartners.org | |||
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Developer of instruments, reagents and kits for clinical diagnostics and life science research | 1995 | luminexcorp.com | Austin, United States |
Investor details for Nanosphere
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Nanosphere
95 people are tracked at Nanosphere (49 in leadership, 1 in board & advisors, 45 in team); the tracked headcount is 146.
| Name | Role | Group |
|---|---|---|
Kristie Brok | HR Director Benelux, France, Iberia & LTG EMEA | Leadership |
Josh Glason | Vice President Asia Pacific | Leadership |
Jesse Nergard | Director Of Talent Acquisition, North America | Leadership |
Doug Whitman | Senior Director, Advanced Technology Group At Luminex Corporation, A Diasorin Company | Leadership |
Chen Even | Chief Commercial Officer | Leadership |
Dave Blomberg | Vice President, Sales - Molecular | Leadership |
Amelia Parente | Senior Vice President Corporate HR | Leadership |
Carlo Rosa | CEO | Leadership |
Ralph Michielli | Regional Sales Director | Leadership |
Kristy Hanson | Vice President Of Strategic Accounts | Leadership |
Fabrizio Momblano | Corporate Treasury Director | Leadership |
Leslie Vasquez | Senior Talent Acquisition Partner | Leadership |
Angelo Rago | President, Luminex Corporation | Leadership |
Liana Ryder | Vice President Immuno | Leadership |
Nineveh Sarggis | Senior Director US Commercial Labs East | Leadership |
Fernando Davico | Corporate Vice President Sales Emea, APAC & Latam | Leadership |
Alessandro Pellarin | Corporate VP Commercial Excellence | Leadership |
Joel Cowen | Vice President, Commercial - Immuno | Leadership |
Matteo Pinciroli | Corporate Vice President Market Access | Leadership |
Luca de Rosa | Corporate Director Commercial Business Development | Leadership |
75 more people are available in the full profile.
Complete people profiles for Nanosphere
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Nanosphere
5 dated milestones of Nanosphere across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Nanosphere is founded.
- Funding First funding round of $3.0M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Luminex.
- Funding Latest funding round, Post-IPO, of $971K.
Competitors of Nanosphere
Nanosphere has 3 listed competitors in our database, 3 of them funded. They include Denali Therapeutics, Poseida Therapeutics and Castle Biosciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| denalitherapeutics.com | 2015 | San Francisco, United States | $347M | 377 | Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's. | |
| poseida.com | 2015 | San Diego, United States | $323.78M | 259 | Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies | |
| cernostics.com | 2008 | Pittsburgh, United States | $14.18M | 16 | Precision diagnostic and prognostic tests are developed by Castle Biosciences. |
Detailed competitors of Nanosphere
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Nanosphere
The website of Nanosphere (nanosphere.us) receives about 1.2K visits a month.
- Monthly visits1.2K
▼ 49.4% vs previous month
Websites whose visitors overlap most with Nanosphere. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biofiredx.com | 100% | 35.2K | #1,089,098 | View details | |
schoeller-tech.com | schoeller-tech.com | 88% | – | ||
| genmarkdx.com | 72% | View details |
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Nanosphere (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nanosphere
Complete news archive for Nanosphere
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nanosphere
Nanosphere was founded in 1999 and raised its 1st funding round 1 year after it was founded.
Nanosphere is headquartered in Northbrook, United States. It is registered at Northbrook, Illinois, United States.
Nanosphere is a funded company, having raised a total of $97.75M across 11 funding rounds to date. The company's 1st funding round was a Series B of $5.5M, raised on Mar 2000.
Nanosphere has 146 employees.
Nanosphere was founded in 1999 and is based in Northbrook, United States. Diagnostic tests for personalized medicine are developed and supplied, with a focus on infections in the bloodstream, respiratory tract, and gastrointestinal tract. The Verigene System is employed, incorporating automation and proprietary chemistry for direct nucleic acid and protein detection on a single platform. All tests are constructed using gold nanoparticle probe technology within the healthcare diagnostics sector.
Nanosphere's top competitors include Poseida Therapeutics, Denali Therapeutics and Castle Biosciences.
Nanosphere has 10 investors. Key investors include NIH, Luminex Corporation, Takara Bio, Allen & Company, and SWK Holdings.
Nanosphere operates through Nanosphere, Inc..
Yes. Nanosphere was acquired by Luminex in May 2016.